J. Lang

发表

Aberrant CpG-island methylation has non-random and tumour-type–specific patterns

M. Caligiuri, C. Bloomfield, F. Wright, 2000, Nature Genetics.

Genetic and Chemical Targeting of Epithelial-Restricted with Serine Box Reduces EGF Receptor and Potentiates the Efficacy of Afatinib

J. Datta, A. Mapp, Manchao Zhang, 2013, Molecular Cancer Therapeutics.

Expression and biological effect of urodele fibroblast growth factor 1: relationship to limb regeneration.

K. Dungan, J. Lang, I. Chiu, 2002, The Journal of experimental zoology.

Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.

C. Plass, C. Morrison, C. Eng, 2007, Cancer research.

Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression

E. K. Parkinson, E. Parkinson, J. Lang, 2006, Head & neck.

The effects of reactive species on the tumorigenic phenotype of human head and neck squamous cell carcinoma (HNSCC) cells.

A. Yates, J. Lang, L. Kresty, 2007, Anticancer research.

Oral graft-versus-host disease and programmed cell death: pathogenetic and clinical correlates.

Dongho Kim, J. Kalmar, J. Lang, 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.

J. Datta, Mozaffarul Islam, T. Teknos, 2014, Oral oncology.

microRNA-107 functions as a candidate tumor suppressor gene in head and neck squamous cell carcinoma by down-regulation of protein kinase Cε

Theodoros N. Teknos, J. Datta, Mozaffarul Islam, 2011, Oncogene.

Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies.

C Eng, M. Caligiuri, F. Wright, 2001, Human molecular genetics.

Dysregulation of MicroRNA-34a Expression in Head and Neck Squamous Cell Carcinoma Promotes Tumor Growth and Tumor Angiogenesis

A. Yadav, T. Teknos, B. Kumar, 2012, PloS one.

Suberoylanilide hydroxamic acid (SAHA) reverses chemoresistance in head and neck cancer cells by targeting cancer stem cells via the downregulation of nanog

A. Yadav, T. Teknos, B. Kumar, 2015, Genes & cancer.

p 16 gene alterations in locally advanced squamous cell carcinoma of the head and neck

D. Schuller, R. Gahbauer, K. Jatana, 2006 .

A muscle specific protein “myoferlin” modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus

A. Yadav, T. Teknos, B. Kumar, 2017, Oncogene.

Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.

Christoph Plass, C. Plass, C. Morrison, 2006, Proceedings of the National Academy of Sciences of the United States of America.

p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck.

D. Schuller, R. Gahbauer, K. Jatana, 2006, Oncology reports.

Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells

J. Chalmers, M. Zborowski, D. Schuller, 2009, Biotechnology and bioengineering.

Genome-Wide Hypomethylation in Head and Neck Cancer Is More Pronounced in HPV-Negative Tumors and Is Associated with Genomic Instability

K. Baggerly, S. Colella, K. Richards, 2009, PloS one.

YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels

A. Yadav, T. Teknos, B. Kumar, 2012, Molecular Cancer Therapeutics.

Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck

T. Teknos, J. Chalmers, M. Zborowski, 2012, PloS one.

Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Daren Wang, Richard Spinney, G. Koutras, 2016, Cancer Prevention Research.

Molecular signatures of metastasis in head and neck cancer

Ralf Krahe, Spiridon Tsavachidis, Keith A Baggerly, 2008, Head & neck.

Preclinical Development YM 155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels

A. Yadav, T. Teknos, B. Kumar, 2012 .

Analysis of TGF-β type I receptor for mutations and polymorphisms in head and neck cancers

B. Casto, C. Weghorst, T. Knobloch, 2001 .

Application of immunomagnetic cell enrichment in combination with RT‐PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood

J. Chalmers, M. Zborowski, J. Lang, 2007, Cytometry. Part B, Clinical cytometry.

miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma

J. Datta, A. Mapp, Manchao Zhang, 2015, Molecular Cancer Therapeutics.

Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)

M. Grever, J. Dancey, E. Kraut, 2011, Cancer Chemotherapy and Pharmacology.

Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke

M. Meyerson, J. Derisi, L. Wood, 2015, Head & neck.

Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells.

J. Chalmers, M. Zborowski, D. Schuller, 2009, Molecular pharmaceutics.

Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Daren Wang, Richard Spinney, J. Lang, 2019, Molecular Cancer Therapeutics.

Suberoylanilide hydroxamic acid (SAHA) reverses chemoresistance in head and neck cancer cells by targeting cancer stem cells via the downregulation of nanog

A. Yadav, T. Teknos, J. Lang, 2015, Genes & cancer.